Dr. Michael L. Swerdlow, MD

Dr. Swerdlow practices at Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein.

Dr. Swerdlow's NPI, 1225113541, was assigned on October 26, 2006. Dr. Swerdlow graduated from Perelman School of Medicine at the University of Pennsylvania in 1967. Dr. Swerdlow holds New York license 104171.

Dr. Swerdlow's primary practice is Montefiore Einstein Hospital-Moses Campus, at 111 East 210th Street, Bronx, NY 10467 in Bronx County. The practice phone is (718) 920-4321.

Dr. Swerdlow's primary practice is Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein. Dr. Swerdlow is also affiliated with White Plains Hospital. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Dr. Swerdlow to 1 more hospital, 1 group practice or clinic and 1 school health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Swerdlow practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Swerdlow's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Swerdlow is licensed in New York.

CMS data shows 370 Medicare services from Dr. Swerdlow across 5 procedure codes in 2024, for 240 Medicare patients. Medicare paid $38,995 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 240 Medicare patients who saw Dr. Swerdlow in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Swerdlow's median patient age at 71, with 70% women.

In 2024, Dr. Swerdlow wrote 1,179 Medicare Part D claims for 178 patients. 81% of them were for generic drugs. CMS names the drug for 873 of them, across 27 drugs with 11 or more claims each, at $1,109,651 in total drug cost. In 2023, CMS named 868 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Swerdlow for performance year 2024, reported as part of a group. CMS lists Dr. Swerdlow as offering telehealth.

Dmand AI links 3 papers to Dr. Swerdlow, published from 2014 to 2015. Dr. Swerdlow's most frequent co-authors are Matthew Stuart Robbins, MD, Nicholas J. Connors, MD and Nancy E. Judge, MD.

CMS Open Payments shows 55 general payments to Dr. Swerdlow from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Alexion Pharmaceuticals, Inc. paid the most, $275.

Dr. Swerdlow graduated from Perelman School of Medicine at the University of Pennsylvania in 1967.